chr22-24183629-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_019601.4(SUSD2):c.422C>T(p.Ala141Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000101 in 1,611,958 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_019601.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SUSD2 | NM_019601.4 | c.422C>T | p.Ala141Val | missense_variant | 3/15 | ENST00000358321.4 | NP_062547.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SUSD2 | ENST00000358321.4 | c.422C>T | p.Ala141Val | missense_variant | 3/15 | 1 | NM_019601.4 | ENSP00000351075 | P1 | |
SUSD2 | ENST00000463101.1 | n.826C>T | non_coding_transcript_exon_variant | 2/11 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000460 AC: 70AN: 152246Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000120 AC: 30AN: 249482Hom.: 0 AF XY: 0.0000962 AC XY: 13AN XY: 135134
GnomAD4 exome AF: 0.0000637 AC: 93AN: 1459594Hom.: 0 Cov.: 32 AF XY: 0.0000565 AC XY: 41AN XY: 726188
GnomAD4 genome AF: 0.000459 AC: 70AN: 152364Hom.: 0 Cov.: 33 AF XY: 0.000456 AC XY: 34AN XY: 74502
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.422C>T (p.A141V) alteration is located in exon 3 (coding exon 3) of the SUSD2 gene. This alteration results from a C to T substitution at nucleotide position 422, causing the alanine (A) at amino acid position 141 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at